Deborah A. Griffin, Chief Accounting Officer at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 2,376 shares at $7.83 ($19K) on 2019-09-18, disclosed to the SEC on 2019-09-20.
Open-market sale of $19k TEVA by Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TEVA | SELL | 2020-03-04 | $47K | — | Filing → |
| TEVA | SELL | 2019-03-19 | $16K | — | Filing → |
| TEVA | SELL | 2019-03-14 | $15K | — | Filing → |